In the face of a persistent decline and stagnation in research and development funding, scientists and engineers must devote more time and effort toward keeping the economic and societal value of science in the public and advocate for it to hold a higher standing in the federal budget. Published in vol. 2, issue 1, of The Journal of Science Policy and Governance.
Kenneth M. Evans, Kirstin R.W. MatthewsMay 6, 2012
This paper posits that the structure of fiscal federalism in countries like Argentina causes voters to reward fiscal expansion because they perceive that this extra spending at the margin is not financed by them, but rather by the nation at large.
Mark P. Jones, Osvaldo Meloni, Mariano TommasiApril 13, 2012
This article reviews the achievements and limitations of the G-20, analyzes the legitimacy issues that the group faces, and presents the basis of a proposal to create a Global Economic Coordination Council.
José Antonio Ocampo, Joseph E. StiglitzJanuary 25, 2012
A rise in the average age of biomedical researchers might inhibit research potential and novel projects that could impact biomedicine and the next generation of scientists in the United States.
The NIH, which has an annual budget of over US$31 billion, is the world’s largest biomedical research agency and is a major strength for science in the U.S. Despite the political nature of stem cell research, this area of science has flourished across the country. In 2010, the NIH funded approximately US$1.3 billion in stem cell research. According to the ISI Web of Science, more than 4,000 U.S.-authored stem cell publications were produced in 2010 — approximately 40% of the world total. The average citation rate was 4.12 per article, with six articles amassing 100 citations in less than 18 months after release.